Godavari Biorefineries Limited (GBL) has released its unaudited consolidated financial results for the quarter and nine months ending December 31, 2025. The results show mixed performance, on account of cost challenges, inventory variations, and volatility across its segments, including sugar, cogeneration, and bio-based chemicals.
For the quarter concluding on December 31, 2025 (Q3 FY26), the company achieved:
- Total Income: ₹46,190.85 lakh
- Revenue from Operations: ₹45,985.25 lakh
- Profit Before Exceptional Items & Tax: ₹2,137.02 lakh
- Profit After Tax (PAT): ₹825.24 lakh
There has been a significant rebound from the prior quarter (Q2 FY26), during which GBL reported a loss of ₹4,159.24 lakh. Year-over-year comparison shows PAT rising from ₹576.17 lakh in Q3 FY25 to ₹825.24 lakh this quarter, indicating enhanced operational effectiveness despite high raw material costs.
The improvement can be attributed to stabilisation in inventory adjustments and stronger segment performance—particularly in bio-based chemicals.
For the nine months ending December 31, 2025:
- Total Income: ₹1,43,015.27 lakh
- Revenue from Operations: ₹1,42,383.96 lakh
- Loss Before Tax: ₹6,571.04 lakh
- Loss After Tax: ₹4,935.68 lakh
Sugar
- Q3 FY26 Operating Profit: ₹2,249.69 lakh
- Significant recovery after previous quarter’s loss
- Boosted by improved pricing and seasonal crushing activities
Cogeneration
- Q3 FY26 Operating Profit: ₹403.90 lakh
- Returned to profitability following prior-quarter losses
Bio-based Chemicals
- Q3 FY26 Operating Profit: ₹803.89 lakh
- Nine-month profit: ₹2,973.39 lakh
- Remains the most stable and growth-focused segment
Distillery
- Q3 FY26 Operating Loss: ₹75.01 lakh
- Nine-month profit: ₹720.67 lakh
The bio-based chemicals division has established itself as a crucial earnings stabiliser that reinforces GBL’s identity as a diversified biorefinery rather than solely a sugar producer.
